Detalhe da pesquisa
1.
Treatment with Dalteparin is Associated with a Lower Risk of Bleeding Compared to Treatment with Unfractionated Heparin in Patients with Renal Insufficiency.
J Gen Intern Med
; 31(2): 182-187, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26209179
2.
Persistent neutrophilia is a marker for an increased risk of venous thrombosis.
J Thromb Thrombolysis
; 42(4): 545-51, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27383828
3.
Identifying Neutrophil Extracellular Traps (NETs) in Blood Samples Using Peripheral Smear Autoanalyzers.
Life (Basel)
; 13(3)2023 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36983779
4.
Saddle Pulmonary Embolism: Demographics, Clinical Presentation, and Outcomes.
Crit Care Explor
; 3(6): e0437, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34136820
5.
Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists.
Res Pract Thromb Haemost
; 5(6): e12574, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34532628
6.
Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality.
Thromb Haemost
; 120(12): 1691-1699, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33186991
7.
Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.
Lancet Haematol
; 6(7): e359-e365, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31133411
8.
Direct oral Xa inhibitors for the treatment of venous thromboembolism after bariatric surgery.
Blood Adv
; 7(2): 224-226, 2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35640233
9.
Direct oral factor Xa inhibitors in patients with morbid obesity - Author's reply.
Lancet Haematol
; 6(9): e447, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31471007